Updated Overall Survival of Ribociclib plus Endocrine Therapy versus Endocrine Therapy Alone in Pre- and Perimenopausal Patients with HR+/HER2− Advanced Breast Cancer in MONALEESA-7: A Phase III Randomized Clinical Trial-Reference-Cited by-同舟云学术

Updated Overall Survival of Ribociclib plus Endocrine Therapy versus Endocrine Therapy Alone in Pre- and Perimenopausal Patients with HR+/HER2− Advanced Breast Cancer in MONALEESA-7: A Phase III Randomized Clinical Trial

Published:2021-12-29 Issue: Volume: Page:
ISSN:1078-0432
Container-title:Clinical Cancer Research
language:en
Short-container-title:Clin Cancer Res

Author:

Lu Yen-Shen^ORCID,Im Seock-Ah^ORCID,Colleoni Marco^ORCID,Franke Fabio,Bardia Aditya,Cardoso Fatima^ORCID,Harbeck Nadia^ORCID,Hurvitz Sara,Chow Louis,Sohn Joohyuk,Lee Keun Seok^ORCID,Campos-Gomez Saul^ORCID,Villanueva Vazquez Rafael,Jung Kyung Hae^ORCID,Babu K. Govind,Wheatley-Price Paul,De Laurentiis Michelino^ORCID,Im Young-Hyuck,Kuemmel Sherko^ORCID,El-Saghir Nagi^ORCID,O'Regan Ruth,Gasch Claudia,Solovieff Nadia,Wang Craig,Wang Yongyu,Chakravartty Arunava,Ji Yan^ORCID,Tripathy Debu^ORCID

Funder

Novartis Pharmaceuticals Corporation

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 123 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Abemaciclib increases the risk of venous thromboembolism in breast cancer: Integrate meta-analysis, pharmacovigilance database analysis, and in vitro validation;Cancer Treatment Reviews;2024-11

2. The impact of previous therapy on overall-survival in registration clinical trials for 1st line metastatic breast cancer a systemic review;Critical Reviews in Oncology/Hematology;2024-10

3. Adjuvant and neoadjuvant therapy with or without CDK4/6 inhibitors in HR+/HER2- early breast cancer: a systematic review and meta-analysis;Frontiers in Pharmacology;2024-09-12

4. Mechanisms of sensitivity and resistance to CDK4/CDK6 inhibitors in hormone receptor-positive breast cancer treatment;Drug Resistance Updates;2024-09

5. Niveles de creatinina elevados y cistatina normales en un paciente que recibe ribociclib;Nefrología;2024-09